Follow
Geniece M. Lehmann
Geniece M. Lehmann
Toxicologist, U.S. EPA
Verified email at epa.gov
Title
Cited by
Cited by
Year
Immune mechanisms in thyroid eye disease
GM Lehmann, SE Feldon, TJ Smith, RP Phipps
Thyroid 18 (9), 959-965, 2008
1862008
Electrophilic peroxisome proliferator–activated receptor-γ ligands have potent antifibrotic effects in human lung fibroblasts
HE Ferguson, A Kulkarni, GM Lehmann, TM Garcia-Bates, TH Thatcher, ...
American journal of respiratory cell and molecular biology 41 (6), 722-730, 2009
1042009
Evaluating health risks from inhaled polychlorinated biphenyls: research needs for addressing uncertainty
GM Lehmann, K Christensen, M Maddaloni, LJ Phillips
Environmental Health Perspectives 123 (2), 109-113, 2015
1032015
Environmental chemicals in breast milk and formula: exposure and risk assessment implications
GM Lehmann, JS LaKind, MH Davis, EP Hines, SA Marchitti, C Alcala, ...
Environmental Health Perspectives 126 (9), 096001, 2018
962018
The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation
GM Lehmann, X Xi, AA Kulkarni, KC Olsen, SJ Pollock, CJ Baglole, ...
The American journal of pathology 178 (4), 1556-1567, 2011
692011
p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1
BF Taylor, SC McNeely, HL Miller, GM Lehmann, MJ McCabe
Journal of Pharmacology and Experimental Therapeutics 318 (1), 142-151, 2006
672006
Ocular fibroblast diversity: implications for inflammation and ocular wound healing
X Xi, DH McMillan, GM Lehmann, PJ Sime, RT Libby, KR Huxlin, ...
Investigative ophthalmology & visual science 52 (7), 4859-4865, 2011
602011
Infant dietary exposures to environmental chemicals and infant/child health: a critical assessment of the literature
JS LaKind, GM Lehmann, MH Davis, EP Hines, SA Marchitti, C Alcala, ...
Environmental health perspectives 126 (9), 096002, 2018
512018
Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk
GM Lehmann, MA Verner, B Luukinen, C Henning, SA Assimon, ...
Critical reviews in toxicology 44 (7), 600-617, 2014
462014
Novel anti-adipogenic activity produced by human fibroblasts
GM Lehmann, CF Woeller, SJ Pollock, CW O'Loughlin, S Gupta, ...
American Journal of Physiology-Cell Physiology 299 (3), C672-C681, 2010
412010
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies
TM Garcia-Bates, GM Lehmann, PJ Simpson-Haidaris, SH Bernstein, ...
PPAR research 2008, 2008
402008
Regulation of lymphocyte function by PPARγ: relevance to thyroid eye disease-related inflammation
GM Lehmann, TM Garcia-Bates, TJ Smith, SE Feldon, RP Phipps
PPAR research 2008, 2008
402008
Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don’t We Know More?
JS LaKind, MA Verner, RD Rogers, H Goeden, DQ Naiman, SA Marchitti, ...
Environmental health perspectives 130 (2), 025002, 2022
372022
A state-of-the-science review of polychlorinated biphenyl exposures at background levels: Relative contributions of exposure routes
CA Weitekamp, LJ Phillips, LM Carlson, NM DeLuca, EAC Hubal, ...
Science of the Total Environment 776, 145912, 2021
342021
The PPAR-platelet connection: modulators of inflammation and potential cardiovascular effects
SL Spinelli, JJ O'brien, S Bancos, GM Lehmann, DL Springer, N Blumberg, ...
PPAR research 2008, 2008
322008
The role of epidemiology studies in human health risk assessment of polychlorinated biphenyls
K Christensen, LM Carlson, GM Lehmann
Environmental Research 194, 110662, 2021
302021
Arsenite slows S phase progression via inhibition of cdc25A dual specificity phosphatase gene transcription
GM Lehmann, MJ McCabe Jr
Toxicological sciences 99 (1), 70-78, 2007
302007
Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring
AE Kuriyan, GM Lehmann, AA Kulkarni, CF Woeller, SE Feldon, ...
Experimental eye research 94 (1), 136-145, 2012
262012
Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification
DR Germolec, H Lebrec, SE Anderson, GR Burleson, A Cardenas, ...
Environmental Health Perspectives 130 (10), 105001, 2022
182022
Integrating data gap filling techniques: A case study predicting TEFs for neurotoxicity TEQs to facilitate the hazard assessment of polychlorinated biphenyls
P Pradeep, LM Carlson, R Judson, GM Lehmann, G Patlewicz
Regulatory Toxicology and Pharmacology 101, 12-23, 2019
152019
The system can't perform the operation now. Try again later.
Articles 1–20